- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01010763
A Study on M2a Magnum Total Hip Arthroplasty
A Prospective Controlled Multi-Center Study on M2a Magnum Total Hip Arthroplasty
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Hyogo Pref.
-
Amagasaki, Hyogo Pref., Japan, 660-8511
- Kansai Rosai Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients suitable for primary Total Hip Replacement
- Patients aged over 20
- Patients with limited co-morbidity- ASA I-III
- Patients must be able to understand instructions and be willing to return for follow-up
- Patients willing to provide blood and urine samples for metal ion analysis at follow-up
Exclusion Criteria:
- Pre-existing metal implants
- Infection, sepsis, and osteomyelitis
- Uncooperative patient or pt with neurologic disorders who are incapable of following directions
- Osteoporosis
- Metabolic disorders which may impair bone formation
- osteomalacia
- distant foci of infections which may spread to the implant site
- rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram
- vascular insufficiency, muscular atrophy, or neuromuscular disease
- pregnancy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: M2a Magnum
Total HIp Arthroplasty using with the M2a Magnum Large Metal Articulation is an ultra-high performance metal-on-metal articulation with a big ball (greater than or equal to 38mm) in acetabulums as small as 44mm.
|
Degenerated hip is replaced with implantable devices, which include femoral stem, acetabular cup, femoral head and acetabular liner(control group only).
|
|
Active Comparator: M2a Taper
Total Hip Arthroplasty using with the M2a Taper Acetabular System consists of a titanium outer shell with cobalt chromium (Co-Cr-Mo) metallic liner, which articulates with with a cobalt chromium (Co-Cr-Mo) modular femoral head.
|
Degenerated hip is replaced with implantable devices, which include femoral stem, acetabular cup, femoral head and acetabular liner(control group only).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Range of Motion
Time Frame: 1 year
|
Hip Flexion Angle at 1 year postoperatively
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Metal Ion
Time Frame: 3 month
|
Blood Cobalt Ion Concentration 0 was imputed for the measurement result being below detection limit.
|
3 month
|
|
UCLA Activity Score
Time Frame: 5 year
|
UCLA is physician assessing scoring system to assess patient's activity level. Minimum score is 0 (completely inactive) and maximum score is 9 (Regularly participates in impact sports) with 1 point increments depending on patient's activity level. Higher score means higher activity level achieved. |
5 year
|
|
Radiographic Assessment
Time Frame: 5 year
|
number of participants, whose x-ray shows any signs of radiographic changes (osteolysis, heterotopic ossification and/or radiolucency)
|
5 year
|
|
Harris Hip Score
Time Frame: 5 year
|
Harris Hip Score is physician assessing hip functional scoring system, which includes 4 components (pain, function, deformity and range of motion) with minimum score of 0 & maximum score of 100. Maximum & Minimum score of each subscale is pain: 0-44, function: 0-47, Deformity: 0-4 and Range of motion: 0-5. Current report uses summed score of each patient to compare total Harris Hip Score. Higher score means better outcomes. |
5 year
|
|
Metal Ion
Time Frame: 6 month
|
Blood Cobalt Ion Concentration 0 was imputed for the measurement result being below detection limit.
|
6 month
|
|
Metal Ion
Time Frame: 1 year
|
Blood Cobalt Ion Concentration 0 was imputed for the measurement result being below detection limit.
|
1 year
|
|
Metal Ion
Time Frame: 2 year
|
Blood Cobalt Ion Concentration 0 was imputed for the measurement result being below detection limit.
|
2 year
|
|
Metal Ion
Time Frame: 3 year
|
Blood Cobalt Ion Concentration 0 was imputed for the measurement result being below detection limit.
|
3 year
|
|
Metal Ion
Time Frame: 4 year
|
Blood Cobalt Ion Concentration 0 was imputed for the measurement result being below detection limit.
|
4 year
|
|
Metal Ion
Time Frame: 5 year
|
Blood Cobalt Ion Concentration 0 was imputed for the measurement result being below detection limit.
|
5 year
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Kenji Ozono, M.D., Ph.D., Kansai Rosai Hospital
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- INT.CR.RROW2
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Avascular Necrosis
-
The Hospital for Sick ChildrenTerminatedFemoral Head Avascular NecrosisCanada
-
Universidad Autonoma de MadridCompletedAvascular Necrosis of the Femoral HeadItaly, France, Germany, Spain
-
Guangdong Provincial People's HospitalUnknownAvascular Necrosis of Femur Head
-
University Hospital, Basel, SwitzerlandWithdrawnAvascular Necrosis of the Femoral Head
-
R-BioSMG-SNU Boramae Medical CenterCompletedAvascular Necrosis of the Femoral HeadKorea, Republic of
-
Pei-Yuan Lee, MDAeon Biotechnology CorporationUnknownBone Marrow | Avascular Necrosis of FemurTaiwan
-
Zimmer BiometActive, not recruitingOsteoarthritis, Hip | Avascular Necrosis of Hip | Post-traumatic; Arthrosis | Avascular Necrosis of the Femoral HeadNetherlands, United States, Denmark, Japan, Norway, Sweden
-
The First Affiliated Hospital of Xinxiang Medical...RecruitingAvascular Necrosis of Femur HeadChina
-
Zimmer BiometCompletedArthritis | Avascular NecrosisBelgium
-
Zimmer BiometAarhus University HospitalCompletedArthritis | Avascular NecrosisDenmark
Clinical Trials on Total Hip Arthroplasty
-
Smith & Nephew, Inc.Active, not recruitingAdvanced Degeneration of the Hip Joint | Revision of the Hip JointUnited States, Australia, Canada, Hong Kong
-
Masarykova Nemocnice v Usti nad Labem, Krajska...CompletedArthropathy of HipCzechia
-
Suzhou MicroPort OrthoRecon Co. LTDCompleted
-
Istituto Clinico HumanitasCompleted
-
University of ConnecticutCompletedOsteo Arthritis Knee | Hip Osteoarthritis | Protein-Energy Malnutrition | Orthopedic | Energy Malnutrition ProteinUnited States
-
Orthopedic Hospital Vienna SpeisingCompletedTotal Hip ArthroplastyAustria
-
Istanbul University - Cerrahpasa (IUC)CompletedObesity | ArthropathyTurkey
-
DePuy OrthopaedicsTerminatedOsteoarthritis | Degenerative Arthritis | Revision ArthroplastyCanada
-
Rothman Institute OrthopaedicsCompleted
-
Western University, CanadaRecruiting